RBC and Bleeding Disorders VI Flashcards

1
Q

prothrombin time

A

PT

extrinsic and common pathways

V, VII, X, PT, fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

partial thromboplastin time

A

PTT

intrinsic and common pathways

V, VIII, IX, X, XI, XII, PT, fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

platelet count

A

best confirmed by PBS inspection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

petechia and purpura in skin or mucous membranes

A

bleeding disorders caused by vessel wall abnormalities

normal PT, PTT and platelet count

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

infection causing bleeding disorders with vessel wall abnormalities

A

meningococcemia
infective endocarditis
rickettsioses

vasculitis and DIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

leukocytoclastic vasculitis

A

hypersensitivity

with drug rxns

immune complex deposition in vessel walls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

scurvy

A

microvascular bleeding resulting from collagen defect weakening vessel wall

vit C deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ehler danlos syndrome

A

microvascular bleeding resulting from collagen defect weakening vessel wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

cushing syndrome

A

excess corticosteroid causes loss of vascular supporting tissue

bleeding disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

henoch schonlein purpura

A

systemic immune disorder

purpuric rash, colicky pain, polyarthralgia and acute glomerulonephritis

deposition of immune complexes of IgA throughout body and within glomerular mesangial region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

purpuric rash, colicky pain, polyarthralgia and acute glomerulonephritis

A

henoch schonlein purpura

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

weber osler rendu syndrome

A

hereditary hemorrhagic telangiectasia

auto dominant

mutation in genes regulating TGF-beta signaling

dilated, turtous blood vessels with thin walls - serious bleeding

nose, tongue, month, eye, GI bleeds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

perivascular amyloidosis

A

weak blood vessels

bleeding disorder

most common with amyloid light chain

often mucocutaneous petechiae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

severe bleeding

A

hereditary hemorrhagic telangiectasia

-weber osler rendu syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

thrombocytopenia

A

platelets < 100,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

posttraumatic bleeding

A

20-50,000 platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

spontaneous bleeding

A

<20,000 platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

bleeding from thrombocytopenia

A

normal PT and PTT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

most feared with low platelets

A

intracranial bleeds

20
Q

causes of thrombocytopenia

A

1 decreased platelet production
2 decreased platelet survival
3 sequestration
4 dilution

21
Q

decreased platelet production

A

drugs and alcohol

HIV - infect megakaryocytes

22
Q

decreased platelet survival

A

immunologic and nonimmunologic

23
Q

immune thrombocytopenia

A

deposition of Abs or immune complexes on platelets

24
Q

fetus thrombocytopenia

A

alloantibodies

IgG antibodies made in mother can cause thrombocytopenia in fetus

25
nonimmunologic destruction of platelets
mechanical injury - metal prosthetic heart valves
26
splenomegaly
platelets can be sequestered thrombocytopenia occurs
27
massive transfusions
can lead to dilutional thrombocytopenia
28
chronic ITP
caused by autoAb mediated destruction of platelets can be idiopathic or secondary secondary - SLE, HIV, B cell neoplasms can be improved by splenectomy - major site of removal of opsonized platelets and removal of source of antoAbs - plasma cells
29
autoAbs in chronic ITP
against platelet membrane glycoproteins IIb-IIIa, or Ib-IX IgG class
30
increased megakaryocytes in BM
seen in chronic ITP also see large platelets on peripheral blood - megathrombocytes and normal sized spleen
31
chronic ITP clinical
adult women < 40yo boeeding into skin and mucosal surfaces petechiae - pinpoint easy bruising, nosebleeds, bleeding from gums, melena, hematuria, excessive menstruation intracranial bleeds fatal - rare in treated pts normal PT and PTT dx of exclusion**
32
chronic ITP and splenomegaly
probably not primary - idiopathic look at B cell neoplasm secondary cause
33
acute ITP
disease of children equal frequency both sexes 1-2 weeks after viral infection resolves spontaneously within 6 months
34
tx of ITP
glucocorticoid - in chronic - and in acute if severe
35
acute ITP without viral prodrome
worse prognosis
36
drug induced thrombocytopenia
quinine, quinidine, vancomycin
37
HIT
heparin induced thrombocytopenia type I - rapidly after start heparin therapy and goes away type II - 2 weeks after heparin - severe arterial/venous thrombosis
38
type I HIT
rapidly after start heparin therapy and goes away
39
type II HIT
2 weeks after heparin - severe arterial/venous thrombosis Abs for heparin and platelet factor 4 DVT, PE, vascular insufficiency
40
HIV thrombocytopenia
common heme manifestation of HIV CD4 and CXCR4 - on megakaryocytes -HIV receptors these cells apoptose and don't produce platelets
41
thrombotic microangiopathy
includes TTP and HUS excessive platelet activation - deposit as thrombi in small blood vessels
42
fever, thrombocytopenia, microangiopathic hemolytic anemia, transient neuro deficits, renal failure
pentad of TTP
43
TTP vs. HUS
TTP - neuro sx HUS - no neuro sx both have normal PT and PTT
44
microangiopathic hemolytic anemia, thrombocytopenia, acute renal failure, children
HUS
45
deficiency of ADAMTS13
TTP tx plasmaphaesis
46
E.Coli 0157:H7 infection
typical HUS
47
deficiency of complement factor H, CD46, or factor I
atypical HUS inhibitors of alternate complement pathways